SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2hq6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HVY_C_D16C416_1
(THYMIDYLATE SYNTHASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 11 PHE A 114
GLU A 122
LEU A 117
GLY A  60
PHE A  61
 GOL  A 176 ( 4.5A)
None
None
None
None
 1.31A 1hvyC-2hq6A:
undetectable		 1hvyC-2hq6A:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I00_A_D16A315_1
(THYMIDYLATE SYNTHASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 9 PHE A 114
GLU A 122
LEU A 117
GLY A  60
PHE A  61
 GOL  A 176 ( 4.5A)
None
None
None
None
 1.14A 1i00A-2hq6A:
undetectable		 1i00A-2hq6A:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LH6_A_NIOA155_1
(LEGHEMOGLOBIN A
(NICOTINATE MET))		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 7 PHE A  40
PHE A 113
PHE A 115
PHE A  54
VAL A  15
 None
 1.42A 1lh6A-2hq6A:
undetectable		 1lh6A-2hq6A:
22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_B_ADNB1246_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		4 / 8 GLY A 131
VAL A  99
MET A 101
ILE A  26
 None
 0.84A 1pk7B-2hq6A:
undetectable		 1pk7B-2hq6A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2TSR_C_D16C509_1
(THYMIDYLATE SYNTHASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 10 PHE A 114
GLU A 122
LEU A 117
GLY A  60
PHE A  61
 GOL  A 176 ( 4.5A)
None
None
None
None
 1.08A 2tsrC-2hq6A:
undetectable		 2tsrC-2hq6A:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB3_A_SAMA1102_0
(STRUCTURAL PROTEIN
VP3)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 12 ILE A  26
GLY A 131
ALA A  33
ALA A 100
VAL A  99
 None
 0.93A 3jb3A-2hq6A:
undetectable		 3jb3A-2hq6A:
10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 9 PHE A 113
VAL A  15
PHE A  54
ILE A 161
PHE A 115
 None
 1.22A 3t3rB-2hq6A:
undetectable		 3t3rB-2hq6A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 9 PHE A 113
VAL A  15
PHE A  54
ILE A 161
PHE A 115
 None
 1.21A 3t3rC-2hq6A:
undetectable		 3t3rC-2hq6A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_D_9PLD501_1
(CYTOCHROME P450 2A6)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 10 PHE A 113
VAL A  15
PHE A  54
ILE A 161
PHE A 115
 None
 1.24A 3t3rD-2hq6A:
undetectable		 3t3rD-2hq6A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_H_ACTH502_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		3 / 3 SER A  73
GLY A  74
GLN A 112
 None
 0.50A 3v4tH-2hq6A:
undetectable		 3v4tH-2hq6A:
18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_A_NCTA501_1
(CYTOCHROME P450 2A6)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 7 PHE A 113
PHE A  54
THR A  19
ILE A  24
PHE A 115
 None
 1.15A 4ejjA-2hq6A:
undetectable		 4ejjA-2hq6A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_B_NCTB501_1
(CYTOCHROME P450 2A6)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		4 / 7 PHE A 113
PHE A  54
THR A  19
PHE A 115
 None
 0.97A 4ejjB-2hq6A:
undetectable		 4ejjB-2hq6A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_B_PARB500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 9 THR A 137
GLU A  27
ARG A  95
ASP A  25
GLY A 135
 None
 1.47A 4qb9B-2hq6A:
0.0		 4qb9B-2hq6A:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZE1_A_X2NA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 12 GLY A 135
LEU A  17
PHE A 113
GLY A  65
LEU A 144
 None
 1.22A 4ze1A-2hq6A:
undetectable		 4ze1A-2hq6A:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V5Z_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		5 / 12 PHE A  54
ILE A 161
PHE A 115
PHE A 130
THR A 137
 None
 1.25A 5v5zA-2hq6A:
undetectable		 5v5zA-2hq6A:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DHB_A_BEZA202_0
(HEPATITIS A VIRUS
CELLULAR RECEPTOR 2)		 2hq6 SEROLOGICALLY
DEFINED COLON CANCER
ANTIGEN 10
(Homo
sapiens) 		4 / 6 PHE A  54
ILE A  24
MET A 141
ASN A 140
 None
 1.42A 6dhbA-2hq6A:
undetectable		 6dhbA-2hq6A:
19.54